Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Trump Widely Considers Candidates for Federal Reserve Board, Including Yellen

Trump Widely Considers Candidates for Federal Reserve Board, Including Yellen

ChaincatcherChaincatcher2025/08/12 20:58
Show original

According to ChainCatcher, citing Jinshi News, U.S. Treasury Secretary Bessent stated in an interview with Fox Business Channel that he is optimistic the Senate will confirm Stephen Milan to fill the interim vacancy on the Federal Reserve Board before the Fed's September policy meeting. Bessent revealed that Trump is actively seeking candidates to fill the permanent vacancy on the Federal Reserve Board that will arise in January next year, and is even considering nominating former Fed Chair Janet Yellen.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Starbucks (SBUX.US) officially refutes rumors: clearly denies acquiring Chipotle (CMG.US), focuses on "Back to Starbucks" transformation strategy

Starbucks publicly clarified on Monday that the company has not acquired Chipotle Mexican Grill, putting an end to the previous acquisition rumors.

智通财经•2026/10/12 23:31

BlackRock increases allocation to short-term US Treasuries and lowers US stocks: "Rate hike bets have gone too far," high yields should be prioritized

BlackRock has turned bullish on U.S. Treasury bonds for the first time in six years, upgrading short-term bonds to overweight and downgrading U.S. equities to neutral, stating that rate hike expectations are excessive and it is time to lock in yields.

智通财经•2026/10/12 23:27
BlackRock increases allocation to short-term US Treasuries and lowers US stocks: "Rate hike bets have gone too far," high yields should be prioritized

AstraZeneca (AZN.US) Relizumab's new indication is expected to be included in priority review

Relizumab is a blockbuster product under AstraZeneca, with global sales projected to reach 4.718 billions USD in 2025 (YOY +20.23%).

智通财经•2026/10/12 23:11